They suggested that BV therapy, due to the presence of melittin and phospholipase A2, which have a strong anti-inflammatory function, could help support recovery because even if the patient recovers from the initial SARS-CoV-2 infection, and it may have long-term effects which are known as long-covid because PLA2 binds to the membrane in vivo, causes antibodies to bind with the cell membrane, and stimulates CD8 T cells [1]. Here, CD8A is linked to bacterial vaginosis.